This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ sparfloxacin (antibiotic)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Respiratory Tract Infections: Sparfloxacin is commonly used to treat respiratory tract infections such as community-acquired pneumonia, bronchitis, and sinusitis caused by susceptible bacteria. It is effective against both Gram-positive and Gram-negative bacteria commonly implicated in these infections.

  2. Urinary Tract Infections: Sparfloxacin may be prescribed for the treatment of urinary tract infections (UTIs), including cystitis and pyelonephritis. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and growth.

  3. Skin and Soft Tissue Infections: Sparfloxacin can also be used to treat skin and soft tissue infections caused by susceptible bacteria. These may include cellulitis, abscesses, and wound infections.

  4. Sexually Transmitted Infections (STIs): Sparfloxacin may be used to treat certain sexually transmitted infections caused by bacteria, such as gonorrhea and chlamydia. However, its use for this purpose may be limited due to the emergence of antibiotic resistance and the availability of other treatment options.

  5. Side Effects: Sparfloxacin, like other fluoroquinolone antibiotics, may cause various side effects. Common side effects include gastrointestinal disturbances (nausea, vomiting, diarrhea), headache, dizziness, and rash. Less common but more serious side effects may include tendonitis, tendon rupture, and central nervous system effects such as confusion, hallucinations, and seizures.

  6. Cardiovascular Effects: Sparfloxacin has been associated with rare but potentially serious cardiovascular side effects, including prolongation of the QT interval, which can lead to abnormal heart rhythms (arrhythmias) and torsades de pointes. It is contraindicated in patients with a history of QT prolongation, arrhythmias, or certain cardiac conditions.

  7. Central Nervous System Effects: Sparfloxacin, like other fluoroquinolones, may rarely cause central nervous system adverse effects such as insomnia, anxiety, depression, and agitation. In rare cases, it may also cause seizures or exacerbate pre-existing neurological conditions.

  8. Hepatotoxicity: Sparfloxacin has been associated with rare cases of hepatotoxicity, including elevated liver enzymes and liver damage. Patients should be monitored for signs of liver dysfunction, such as jaundice, abdominal pain, and dark urine, during treatment with sparfloxacin.

  9. Photosensitivity: Like other fluoroquinolone antibiotics, sparfloxacin may increase the risk of sunburn and phototoxic reactions. Patients should be advised to avoid excessive sun exposure and to use sun protection measures (e.g., sunscreen, protective clothing) during treatment.

  10. Drug Interactions: Sparfloxacin may interact with other medications, including antacids containing magnesium or aluminum, sucralfate, and certain anticoagulants. Concurrent use of sparfloxacin with these medications may reduce its absorption or effectiveness.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of sparfloxacin (antibiotic) On Probiotics

Bacteria Impacted by sparfloxacin (antibiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of sparfloxacin (antibiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]